ArticleMetabolic engineering communications2026
Combining automated kinetic model selection with robust optimization and application to maximize cell-free production of UDP-GalNAc.
Article in Metabolic engineering communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell-free multi-enzyme cascades enable precise biosynthesis, but using them for cost-efficient bioproduction remains challenging. This issue can be addressed through model-based process optimization using kinetic models. However, the predictive power of kinetic models is often limited by structural and parametric uncertainties. In this work, we present MoRSel, a novel method that tackles structural uncertainties through automated refinement and selection of kinetic models. MoRSel starts with a kinetic core model, a library of potential model changes, and available experimental data. The algorithm iteratively expands the model to achieve an optimal balance between fit quality and model complexity according to information-theoretic criteria. We applied MoRSel to a kinetic model of a cell-free enzyme cascade for producing the nucleotide sugar UDP-GalNAc. An initial core model showed significant inconsistencies with measured experimental data. By providing candidates for potential stoichiometric and regulatory changes in the model, MoRSel identified a model that more accurately captured the observed behavior. We then used this model to inform a recently introduced robust (ensemble-based) process optimization strategy that accounts for parametric uncertainty. We addressed two economically relevant problems. First, we determined the optimal initial substrate and enzyme concentrations to maximize the product titer, resulting in a 45 % increase in product titer and yield in a validation experiment. In a second optimization, we minimized the enzyme load and tested the computed optimal enzyme concentrations in another validation experiment. With enzyme costs reduced by 53 %, the relative titer and yield could be improved by 80 % and 75 %, respectively, with small reductions in absolute titer and yield. Overall, MoRSel advances the development of predictive models for complex biochemical systems, with particular relevance for the robust optimization of cell-free bioproduction processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.